NIH-funded research NIH-funded research

Understanding how protein acetylation affects bacteria

Official title: Investigation of the physiological significance of protein acetylation in Bacillus subtilis

Funded at Rowan University · NIH-10873748 · Data updated 2026-11-12

This study looks at how a tiny change in proteins, called acetylation, affects how a common bacterium called Bacillus subtilis works, especially focusing on a protein similar to those found in our cells, to learn more about how it helps the bacteria manage important tasks like gene activity and organizing their genetic material.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRowan University
NIH-funded
Lab location1 site (Glassboro, United States)
Project startSeptember 1, 2020
Project endJune 30, 2025
Funding year2024
Award (this year)$365,086
NIH project number5R35GM138303-05
Project IDNIH-10873748 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would be individuals interested in the molecular biology of bacteria or those affected by bacterial infections.

Less likely to help

Patients with conditions unrelated to bacterial infections or those not interested in microbiological research may not receive any benefit from this research.

What this research studies

This research investigates the role of protein acetylation in the bacterium Bacillus subtilis, focusing on how this modification influences various cellular functions. By studying a specific protein known as HBsu, which is similar to histones in eukaryotes, the research aims to uncover the mechanisms behind acetylation and its impact on bacterial physiology. The approach involves identifying acetylation sites and understanding their significance in cellular processes such as gene expression and chromosome organization.

Why it matters

Potential benefit: If successful, this research could lead to new insights into bacterial behavior and potentially inform the development of novel antibacterial strategies.

How similar studies have gone: While the study of protein acetylation in bacteria is a relatively new field, previous research has shown promising results in understanding similar modifications in other organisms.

Where this research is happening

  • Rowan University
    Glassboro, United States
    Active

Researchers

  • Principal investigator: Carabetta, Valerie Jean — Rowan University
  • Study coordinator: Carabetta, Valerie Jean

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.